PPARγ Agonists Promote Oligodendrocyte Differentiation of Neural Stem Cells by Modulating Stemness and Differentiation Genes

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Kanakasabai, Saravanan ^a   Pestereva, Ecaterina ^a   Chearwae, Wanida ^a   Gupta, Sushil K ^a   Ansari, Saif ^a   Bright, John J ^a,b  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; BETA TUBULIN; CIGLITAZONE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GLIAL FIBRILLARY ACIDIC PROTEIN; NESTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; RETINOIC ACID;

ANIMAL CELL; ARTICLE; ASTROCYTE; BXDC2 GENE; CELL PROLIFERATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CRABP2 GENE; DNMT3B GENE; DRUG MECHANISM; DRUG TARGETING; GA1 GENE; GABRB3 GENE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IFITM1 GENE; IN VITRO STUDY; KIT GENE; LEFTY1 GENE; LIFR GENE; MOUSE; NANOG GENE; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NEURAL STEM CELL; NODAL GENE; NOG GENE; NONHUMAN; NR6A1 GENE; OLIGODENDROGLIA; PODX1 GENE; PROTEIN EXPRESSION; SOX2 GENE; SRFP2 GENE;

ANIMALS; ANTIGENS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; INTERMEDIATE FILAMENT PROTEINS; MICE; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; OLIGODENDROGLIA; PPAR GAMMA; PROSTAGLANDIN D2; PROTEOGLYCANS; THIAZOLIDINEDIONES; TRETINOIN; TUBULIN;

EID: 84869854776     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050500     Document Type: Article

References (72)

1. Miller FD, Gauthier AS, (2007) Timing is everything: making neurons versus glia in the developing cortex. Neuron 54: 357-369.
2. Weiss S, Reynolds BA, Vescovi AL, Morshead C, Craig CG, et al. (1996) Is there a neural stem cell in the mammalian forebrain? Trends Neurosci 19: 387-393.
3. Gage FH, (2000) Mammalian neural stem cells. Science 287: 1433-1438.
4. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, et al. (1998) Neurogenesis in the adult human hippocampus. Nat Med 4: 1313-1317.
5. Gage FH, (1998) Stem cells of the central nervous system. Curr Opin Neurobiol 8: 671-676.
6. Luskin MB, Zigova T, Soteres BJ, Stewart RR, (1997) Neuronal progenitor cells derived from the anterior subventricular zone of the neonatal rat forebrain continue to proliferate in vitro and express a neuronal phenotype. Mol Cell Neurosci 8: 351-366.
7. Nait-Oumesmar B, Decker L, Lachapelle F, Avellana-Adalid V, Bachelin C, et al. (1999) Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur J Neurosci 11: 4357-4366.
8. Bonaguidi MA, Wheeler MA, Shapiro JS, Stadel RP, Sun GJ, et al. (2011) In Vivo Clonal Analysis Reveals Self-Renewing and Multipotent Adult Neural Stem Cell Characteristics. Cell 145: 1142-1155.
9. Mokry J, Nemecek S, (1999) Cerebral angiogenesis shows nestin expression in endothelial cells. Gen Physiol Biophys 18Suppl 1: 25-29.
10. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, et al. (2000) Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 97: 14720-14725.
11. Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, et al. (2003) Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422: 688-694.
12. Groves AK, Entwistle A, Jat PS, Noble M, (1993) The characterization of astrocyte cell lines that display properties of glial scar tissue. Dev Biol 159: 87-104.
13. Zhang SC, Fedoroff S, (1999) Expression of stem cell factor and c-kit receptor in neural cells after brain injury. Acta Neuropathol 97: 393-398.
14. Shihabuddin LS, Palmer TD, Gage FH, (1999) The search for neural progenitor cells: prospects for the therapy of neurodegenerative disease. Mol Med Today 5: 474-480.
15. Rogister B, Ben-Hur T, Dubois-Dalcq M, (1999) From neural stem cells to myelinating oligodendrocytes. Mol Cell Neurosci 14: 287-300.
16. Debril MB, Renaud JP, Fajas L, Auwerx J, (2001) The pleiotropic functions of peroxisome proliferator-activated receptor gamma. J Mol Med 79: 30-47.
17. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, et al. (1994) Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A 91: 7355-7359.
18. Michalik L, Wahli W, (2006) Involvement of PPAR nuclear receptors in tissue injury and wound repair. J Clin Invest 116: 598-606.
19. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM, (1992) Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358: 771-774.
20. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, et al. (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83: 803-812.
21. Jiang C, Ting AT, Seed B, (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86.
22. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, et al. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83: 813-819.
23. Paruchuri S, Jiang Y, Feng C, Francis SA, Plutzky J, et al. (2008) Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells. J Biol Chem 283: 16477-16487.
24. Blaschke F, Caglayan E, Hsueh WA, (2006) Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes. Endocrinol Metab Clin North Am35: 561-574, ix.
25. Desvergne B, Wahli W, (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20: 649-688.
26. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, et al. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270: 12953-12956.
27. Rosen ED, Spiegelman BM, (2001) PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276: 37731-37734.
28. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK, (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82.
29. Allahtavakoli M, Shabanzadeh A, Roohbakhsh A, Pourshanazari A, (2007) Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats. Basic Clin Pharmacol Toxicol 101: 309-314.
30. Culman J, Zhao Y, Gohlke P, Herdegen T, (2007) PPAR-gamma: therapeutic target for ischemic stroke. Trends Pharmacol Sci 28: 244-249.
31. Natarajan C, Bright JJ, (2002) Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation. Genes Immun 3: 59-70.
32. Luna-Medina R, Cortes-Canteli M, Alonso M, Santos A, Martinez A, et al. (2005) Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J Biol Chem 280: 21453-21462.
33. Luna-Medina R, Cortes-Canteli M, Sanchez-Galiano S, Morales-Garcia JA, Martinez A, et al. (2007) NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders. J Neurosci 27: 5766-5776.
34. Bernardo A, Levi G, Minghetti L, (2000) Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions. Eur J Neurosci 12: 2215-2223.
35. Landreth GE, Heneka MT, (2001) Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease. Neurobiol Aging 22: 937-944.
36. Townsend KP, Pratico D, (2005) Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. Faseb J 19: 1592-1601.
37. Kielian T, Drew PD, (2003) Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation. J Neurosci Res 71: 315-325.
38. Ricote M, Huang JT, Welch JS, Glass CK, (1999) The peroxisome proliferator-activated receptor (PPARgamma) as a regulator of monocyte/macrophage function. J Leukoc Biol 66: 733-739.
39. Raikwar HP, Muthian G, Rajasingh J, Johnson CN, Bright JJ, (2006) PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2. J Neuroimmunol 178: 76-86.
40. Wada K, Nakajima A, Katayama K, Kudo C, Shibuya A, et al. (2006) Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation. J Biol Chem 281: 12673-12681.
41. Morales-Garcia JA, Luna-Medina R, Alfaro-Cervello C, Cortes-Canteli M, Santos A, et al. (2011) Peroxisome proliferator-activated receptor gamma ligands regulate neural stem cell proliferation and differentiation in vitro and in vivo. Glia 59: 293-307.
42. Katura T, Moriya T, Nakahata N, (2010) 15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state. Mol Pharmacol 77: 601-611.
43. Stabenfeldt SE, Munglani G, Garcia AJ, LaPlaca MC, (2010) Biomimetic microenvironment modulates neural stem cell survival, migration, and differentiation. Tissue Eng Part A 16: 3747-3758.
44. Sypecka J, Dragun-Szymczak P, Zalewska T, Domanska-Janik K, (2009) Laminin promotes oligogliogenesis and increases MMPs activity in human neural stem cells of HUCB-NSC line. Acta Neurobiol Exp (Wars) 69: 37-45.
45. Sher F, Rossler R, Brouwer N, Balasubramaniyan V, Boddeke E, et al. (2008) Differentiation of neural stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2. Stem Cells 26: 2875-2883.
46. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, et al. (2003) Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17: 126-140.
47. Catena R, Tiveron C, Ronchi A, Porta S, Ferri A, et al. (2004) Conserved POU binding DNA sites in the Sox2 upstream enhancer regulate gene expression in embryonic and neural stem cells. J Biol Chem 279: 41846-41857.
48. D'Amour KA, Gage FH, (2003) Genetic and functional differences between multipotent neural and pluripotent embryonic stem cells. Proc Natl Acad Sci U S A 100Suppl 1: 11866-11872.
49. Episkopou V, (2005) SOX2 functions in adult neural stem cells. Trends Neurosci 28: 219-221.
50. Klassen H, Schwartz MR, Bailey AH, Young MJ, (2001) Surface markers expressed by multipotent human and mouse neural progenitor cells include tetraspanins and non-protein epitopes. Neurosci Lett 312: 180-182.
51. Hendrickx M, Van XH, Leyns L, (2009) Anterior-posterior patterning of neural differentiated embryonic stem cells by canonical Wnts, Fgfs, Bmp4 and their respective antagonists. Dev Growth Differ 51: 687-698.
52. Chaerkady R, Kerr CL, Marimuthu A, Kelkar DS, Kashyap MK, et al. (2009) Temporal analysis of neural differentiation using quantitative proteomics. J Proteome Res 8: 1315-1326.
53. Holmes FE, Mahoney S, King VR, Bacon A, Kerr NC, et al. (2000) Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity. Proc Natl Acad Sci U S A 97: 11563-11568.
54. O'Meara G, Coumis U, Ma SY, Kehr J, Mahoney S, et al. (2000) Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proc Natl Acad Sci U S A 97: 11569-11574.
55. Hokfelt T, Wiesenfeld-Hallin Z, Villar M, Melander T, (1987) Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci Lett 83: 217-220.
56. Burazin TC, Gundlach AL, (1998) Inducible galanin and GalR2 receptor system in motor neuron injury and regeneration. J Neurochem 71: 879-882.
57. Rutherfurd SD, Widdop RE, Louis WJ, Gundlach AL, (1992) Preprogalanin mRNA is increased in vagal motor neurons following axotomy. Brain Res Mol Brain Res 14: 261-266.
58. Sun Y, Meijer DH, Alberta JA, Mehta S, Kane MF, et al. (2011) Phosphorylation state of Olig2 regulates proliferation of neural progenitors. Neuron 69: 906-917.
59. Brzozowski T, Konturek PC, Pajdo R, Kwiecien SN, Konturek S, et al. (2005) Agonist of peroxisome proliferator-activated receptor gamma (PPAR-gamma): a new compound with potent gastroprotective and ulcer healing properties. Inflammopharmacology 13: 317-330.
60. Okano H, (2002) Neural stem cells: progression of basic research and perspective for clinical application. Keio J Med 51: 115-128.
61. Okano H, (2002) Stem cell biology of the central nervous system. J Neurosci Res 69: 698-707.
62. Lazarovici P, Marcinkiewicz C, Lelkes PI, (2006) Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr Pharm Des 12: 2609-2622.
63. Cho JH, Tsai MJ, (2004) The role of BETA2/NeuroD1 in the development of the nervous system. Mol Neurobiol 30: 35-47.
64. Yokoyama M, Nishi Y, Miyamoto Y, Nakamura M, Akiyama K, et al. (1996) Molecular cloning of a human neuroD from a neuroblastoma cell line specifically expressed in the fetal brain and adult cerebellum. Brain Res Mol Brain Res 42: 135-139.
65. Kaneto H, Miyatsuka T, Kawamori D, Yamamoto K, Kato K, et al. (2008) PDX-1 and MafA play a crucial role in pancreatic beta-cell differentiation and maintenance of mature beta-cell function. Endocr J 55: 235-252.
66. Kaneto H, Matsuoka TA, Miyatsuka T, Kawamori D, Katakami N, et al. (2008) PDX-1 functions as a master factor in the pancreas. Front Biosci 13: 6406-6420.
67. Kubota H, Storms RW, Reid LM, (2002) Variant forms of alpha-fetoprotein transcripts expressed in human hematopoietic progenitors. Implications for their developmental potential towards endoderm. J Biol Chem 277: 27629-27635.
68. Cheng J, Nakamura H, Imanishi H, Liu W, Morisaki T, et al. (2004) Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells. Biochem Biophys Res Commun 322: 458-464.
69. Younes-Rapozo V, Berendonk J, Savignon T, Manhaes AC, Barradas PC, (2006) Thyroid hormone deficiency changes the distribution of oligodendrocyte/myelin markers during oligodendroglial differentiation in vitro. Int J Dev Neurosci 24: 445-453.
70. Fox MA, Alexander JK, Afshari FS, Colello RJ, Fuss B, (2004) Phosphodiesterase-I alpha/autotaxin controls cytoskeletal organization and FAK phosphorylation during myelination. Mol Cell Neurosci 27: 140-150.
71. Mo C, Chearwae W, Bright JJ, (2010) PPARgamma regulates LIF-induced growth and self-renewal of mouse ES cells through Tyk2-Stat3 pathway. Cell Signal 22: 495-500.
72. Rajasingh J, Bright JJ, (2006) 15-Deoxy-delta12,14-prostaglandin J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells. Exp Cell Res 312: 2538-2546.